找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cardiovascular Safety in Drug Development and Therapeutic Use; New Methodologies an J. Rick Turner,Dilip R. Karnad,Snehal Kothari Book 2017

[復(fù)制鏈接]
查看: 20148|回復(fù): 49
樓主
發(fā)表于 2025-3-21 18:22:43 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Cardiovascular Safety in Drug Development and Therapeutic Use
副標(biāo)題New Methodologies an
編輯J. Rick Turner,Dilip R. Karnad,Snehal Kothari
視頻videohttp://file.papertrans.cn/222/221984/221984.mp4
概述Cutting-edge descriptions and explanations of state-of-the-art cardiovascular safety assessments enable readers to get up to speed quickly. No other book provides such a comprehensive overview of one
圖書封面Titlebook: Cardiovascular Safety in Drug Development and Therapeutic Use; New Methodologies an J. Rick Turner,Dilip R. Karnad,Snehal Kothari Book 2017
描述.At a time when the field of cardiac safety is going through important changes, this unique book provides the rationale for, and cutting-edge explanations of, new regulatory landscapes that will likely govern cardiac safety assessments globally for the foreseeable future.? Exposure-response modeling is already being accepted by regulatory agencies in lieu of the traditional Thorough QT/QTc Study, and the Comprehensive .in vitro?.Proarrhythmia Assay initiative is well under way..Developments in the field of cardiovascular safety are also described and discussed in the book.? These include the search for more efficient ways to exonerate new drugs for type 2 diabetes from an unacceptable cardiovascular liability, how best to address off-target blood pressure increases induced by noncardiovascular drugs, and the continued evolution of the discipline of Cardio-oncology..“a resource that will likely serve as a standard for years to come”?.- Dr Jonathan Seltzer.Therapeutic Innovation & Regulatory Science., 2017;51(2):180.“I have no hesitation in recommending this book as a valuable reference source”?.- Dr Rashmi Shah.Journal for Clinical Studies., 2017;9(1):62-63.
出版日期Book 2017
關(guān)鍵詞Proarrhythmic liability; QT interval prolongation; hERG channel blockade; Thorough QT/QTc Study; Regulat
版次1
doihttps://doi.org/10.1007/978-3-319-40347-2
isbn_softcover978-3-319-82085-9
isbn_ebook978-3-319-40347-2
copyrightSpringer International Publishing Switzerland 2017
The information of publication is updating

書目名稱Cardiovascular Safety in Drug Development and Therapeutic Use影響因子(影響力)




書目名稱Cardiovascular Safety in Drug Development and Therapeutic Use影響因子(影響力)學(xué)科排名




書目名稱Cardiovascular Safety in Drug Development and Therapeutic Use網(wǎng)絡(luò)公開度




書目名稱Cardiovascular Safety in Drug Development and Therapeutic Use網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cardiovascular Safety in Drug Development and Therapeutic Use被引頻次




書目名稱Cardiovascular Safety in Drug Development and Therapeutic Use被引頻次學(xué)科排名




書目名稱Cardiovascular Safety in Drug Development and Therapeutic Use年度引用




書目名稱Cardiovascular Safety in Drug Development and Therapeutic Use年度引用學(xué)科排名




書目名稱Cardiovascular Safety in Drug Development and Therapeutic Use讀者反饋




書目名稱Cardiovascular Safety in Drug Development and Therapeutic Use讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:14:58 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:16:21 | 只看該作者
地板
發(fā)表于 2025-3-22 05:51:16 | 只看該作者
J. Rick Turner,Dilip R. Karnad,Snehal KothariCutting-edge descriptions and explanations of state-of-the-art cardiovascular safety assessments enable readers to get up to speed quickly. No other book provides such a comprehensive overview of one
5#
發(fā)表于 2025-3-22 12:22:35 | 只看該作者
http://image.papertrans.cn/c/image/221984.jpg
6#
發(fā)表于 2025-3-22 13:42:46 | 只看該作者
7#
發(fā)表于 2025-3-22 17:24:44 | 只看該作者
978-3-319-82085-9Springer International Publishing Switzerland 2017
8#
發(fā)表于 2025-3-22 22:21:36 | 只看該作者
9#
發(fā)表于 2025-3-23 05:02:09 | 只看該作者
https://doi.org/10.1007/BFb0093144onsequently changing a patient’s biology for the better. Unfortunately, drugs can also lead to undesirable biological consequences, including adverse cardiovascular events. Before discussing the nature of these undesirable consequences and the methodologies for their prospective exclusion in subsequ
10#
發(fā)表于 2025-3-23 06:33:24 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-20 08:44
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
沧州市| 广灵县| 合川市| 泸定县| 丰原市| 嘉祥县| 巫山县| 江山市| 灵石县| 合阳县| 巫溪县| 岚皋县| 惠水县| 讷河市| 塔城市| 南陵县| 阳朔县| 苗栗县| 隆尧县| 平远县| 上思县| 加查县| 怀仁县| 成都市| 平武县| 广河县| 林口县| 禹州市| 临夏市| 张北县| 赤峰市| 永安市| 蓬莱市| 永顺县| 墨竹工卡县| 图片| 巨鹿县| 马鞍山市| 汤阴县| 岳阳县| 张家界市|